PhD-Studiengang Epidemiologie

Der PhD-Studiengang „Epidemiologie“ ist ein dreijähriger Promotionsstudiengang im Bereich der epidemiologischen Forschung und wird von der Abteilung für Epidemiologie des HZI betrieben.

Der PhD-Studiengang ist ein Kooperationsprojekt der Abteilung für Epidemiologie, der  HZI Grad School und der HBRS (MHH). Nach erfolgreichem Abschluss erwerben die Studierenden in der Regel den Titel PhD oder in Einzelfällen Dr. rer nat.

Die Bewerbung und Zulassung zum PhD Programm ist derzeit nur möglich, wenn eine externe Finanzierung gewährleistet ist (zum Beispiel über Stipendium).

Publikationen

Liste der von unseren Studenten im Kontext des PhD-Studiengangs „Epidemiologie“ veröffentlichten Publikationen

Akmatov MK, Mehraj J, Gatzemeier A, Strömpl J, Witte W, Krause G, et al. Serial home-based self-collection of anterior nasal swabs to detect Staphylococcus aureus carriage in a randomized population-based study in Germany. Int J Infect Dis. 2014;25:4-10. doi: 10.1016/j.ijid.2014.01.021. PubMed PMID: 24813875.

Cuny C, Arnold P, Hermes J, Eckmanns T, Mehraj J, Schoenfelder S, et al. Occurrence of cfr-mediated multiresistance in staphylococci from veal calves and pigs, from humans at the corresponding farms, and from veterinarians and their family members. Vet Microbiol. 2017;200:88-94. doi: 10.1016/j.vetmic.2016.04.002. PubMed PMID: 27102205.

Damm O, Horn J, Mikolajczyk R, Greiner W, Siedler A, Weidemann F, et al. Health Economic Evaluation of Different Vaccination Strategies Against Varicella and Herpes Zoster in Germany. Value Health. 2015;18(7):A588. doi: 10.1016/j.jval.2015.09.1503. PubMed PMID: 26533304.

Damm O, Horn J, Schmidt T, Neubauer S, Zeidler J, Mikolajczyk R, et al. Epidemiology and Costs of Varicella and Herpes Zoster in Germany. Value Health. 2014;17(7):A670-1. doi: 10.1016/j.jval.2014.08.2481. PubMed PMID: 27202458.

Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O. Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health. 2015;15:533. doi: 10.1186/s12889-015-1861-8. PubMed PMID: 26041469; PubMed Central PMCID: PMCPMC4455277.

Grylka-Baeschlin S, Petersen A, Karch A, Gross MM. Labour duration and timing of interventions in women planning vaginal birth after caesarean section. Midwifery. 2016;34:221-9. doi: 10.1016/j.midw.2015.11.004. PubMed PMID: 26681573.

Hense S, Hillebrand K, Horn J, Mikolajczyk R, Schulze-Rath R, Garbe E. HPV vaccine uptake after introduction of the vaccine in Germany: an analysis of administrative data. Hum Vaccin Immunother. 2014;10(6):1729-33. doi: 10.4161/hv.28450. PubMed PMID: 24637921; PubMed Central PMCID: PMCPMC5396220.

Horn J, Damm O, Greiner W, Hengel H, Kretzschmar ME, Siedler A, et al. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study. BMC Med. 2018;16(1):3. doi: 10.1186/s12916-017-0983-5. PubMed PMID: 29316913; PubMed Central PMCID: PMCPMC5761134.

Horn J, Damm O, Kretzschmar ME, Delere Y, Wichmann O, Kaufmann AM, et al. Estimating the long-term effects of HPV vaccination in Germany. Vaccine. 2013;31(19):2372-80. doi: 10.1016/j.vaccine.2013.03.006. PubMed PMID: 23518405.

Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, et al. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination. Hum Vaccin Immunother. 2016;12(7):1766-76. doi: 10.1080/21645515.2015.1135279. PubMed PMID: 26835890; PubMed Central PMCID: PMCPMC4964823.

Karo B, Hauer B, Hollo V, van der Werf MJ, Fiebig L, Haas W. Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011. Euro Surveill. 2015;20(49). doi: 10.2807/1560-7917.ES.2015.20.49.30087. PubMed PMID: 26676247.

Karo B, Krause G, Hollo V, van der Werf MJ, Castell S, Hamouda O, et al. Impact of HIV infection on treatment outcome of tuberculosis in Europe. AIDS. 2016;30(7):1089-98. doi: 10.1097/QAD.0000000000001016. PubMed PMID: 26752278.

Mehraj J, Akmatov MK, Strömpl J, Gatzemeier A, Layer F, Werner G, et al. Methicillin-sensitive and methicillin-resistant Staphylococcus aureus nasal carriage in a random sample of non-hospitalized adult population in northern Germany. PloS one. 2014;9(9):e107937. doi: 10.1371/journal.pone.0107937. PubMed PMID: 25251407; PubMed Central PMCID: PMCPMC4176714.

Mehraj J, Witte W, Akmatov MK, Layer F, Werner G, Krause G. Epidemiology of Staphylococcus aureus Nasal Carriage Patterns in the Community. Curr Top Microbiol Immunol. 2016;398:55-87. doi: 10.1007/82_2016_497. PubMed PMID: 27370344.

Mikolajczyk RT, Kraut AA, Horn J, Schulze-Rath R, Garbe E. Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study. Sex Transm Dis. 2013;40(1):28-31. doi: 10.1097/OLQ.0b013e3182756efd. PubMed PMID: 23250300.

Nguyen VK, Binder SC, Boianelli A, Meyer-Hermann M, Hernandez-Vargas EA. Ebola virus infection modeling and identifiability problems. Front Microbiol. 2015;6:257. doi: 10.3389/fmicb.2015.00257. PubMed PMID: 25914675; PubMed Central PMCID: PMCPMC4391033.

Nguyen VK, Hernandez-Vargas EA. Windows of opportunity for Ebola virus infection treatment and vaccination. Sci Rep. 2017;7(1):8975. doi: 10.1038/s41598-017-08884-0. PubMed PMID: 28827623; PubMed Central PMCID: PMCPMC5567060.

Nguyen VK, Klawonn F, Mikolajczyk R, Hernandez-Vargas EA. Analysis of Practical Identifiability of a Viral Infection Model. PLoS One. 2016;11(12):e0167568. doi: 10.1371/journal.pone.0167568. PubMed PMID: 28036339; PubMed Central PMCID: PMCPMC5201286.

Rübsamen N, Castell S, Horn J, Karch A, Ott JJ, Raupach-Rosin H, et al. Ebola risk perception in Germany, 2014. Emerg Infect Dis. 2015;21(6):1012-8. doi: 10.3201/eid2106.150013. PubMed PMID: 25989020; PubMed Central PMCID: PMCPMC4451905.

Schweitzer A, Akmatov MK, Kindler F, Kemmling Y, Kreienbrock L, Krause G, et al. The impact of distance and duration of travel on participation rates and participants' satisfaction: results from a pilot study at one study centre in Pretest 2 of the German National Cohort. BMJ open. 2015;5(8):e007461. doi: 10.1136/bmjopen-2014-007461. PubMed PMID: 26297358; PubMed Central PMCID: PMCPMC4550716.

Schweitzer A, Akmatov MK, Krause G. Hepatitis B vaccination timing: results from demographic health surveys in 47 countries. Bulletin of the World Health Organization. 2017;95(3):199-209G. doi: 10.2471/blt.16.178822.

Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546-55. doi: 10.1016/S0140-6736(15)61412-X. PubMed PMID: 26231459.

Schweitzer A, Krause G, Pessler F, Akmatov MK. Improved coverage and timing of childhood vaccinations in two post-Soviet countries, Armenia and Kyrgyzstan. BMC Public Health. 2015;15(1):798. doi: 10.1186/s12889-015-2091-9. PubMed PMID: 26285702; PubMed Central PMCID: PMCPMC4545703.

Zoch B, Mikolajczyk R (2015) Infections in childhood [German]. Public Health Forum 22: 10-12

Zoch B, Karch A, Dreesman J, Monazahian M, Baillot A, Mikolajczyk RT. Feasibility of a birth cohort study dedicated to assessing acute infections using symptom diaries and parental collection of biomaterials. BMC Infect Dis. 2015;15:436. doi: 10.1186/s12879-015-1189-0. PubMed PMID: 26493700; PubMed Central PMCID: PMCPMC4618955.

Kontakt

Sprecher:
Prof. Dr. Gérard Krause

Koordination:
Dr. Jördis J. Ott
Dr. Stefanie Castell

Abteilung für Epidemiologie
Helmholtz Zentrum für Infektionsforschung
Inhoffenstraße 7
38124 Braunschweig

Telefon: 0531 6181 - 3101
phd-epidemiology@helmholtz-hzi.de

DruckenPer Mail versendenTeilen